A Multicenter Prospective Randomized Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation.

Trial Profile

A Multicenter Prospective Randomized Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Jan 2014

At a glance

  • Drugs Antithymocyte globulin (Primary) ; Busulfan (Primary) ; Fludarabine (Primary) ; Ciclosporin; Mycophenolate mofetil
  • Indications Graft-versus-host disease; Haematological malignancies; Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jan 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
    • 19 Mar 2013 Planned end date changed from 1 Oct 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
    • 08 Nov 2011 Economic results presented at the 14th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top